Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.

about

Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q55432051

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Clinicopathological and progno ...... atic review and meta-analysis.

@en

Clinicopathological and progno ...... atic review and meta-analysis.

@nl

type

Item

label

Clinicopathological and progno ...... atic review and meta-analysis.

@en

Clinicopathological and progno ...... atic review and meta-analysis.

@nl

prefLabel

Clinicopathological and progno ...... atic review and meta-analysis.

@en

Clinicopathological and progno ...... atic review and meta-analysis.

@nl

P1476

Clinicopathological and progno ...... atic review and meta-analysis.

@en

P2093

Chuanxi Zheng

http://www.w3.org/2001/XMLSchema#string

Jifeng Tan

http://www.w3.org/2001/XMLSchema#string

Jinquan Chen

http://www.w3.org/2001/XMLSchema#string

Peng Wan

http://www.w3.org/2001/XMLSchema#string

Shiquan Zhang

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Wei You

http://www.w3.org/2001/XMLSchema#string

Xiaochun Jiang

http://www.w3.org/2001/XMLSchema#string

Yuchen Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2012

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Practical methods for incorporating summary time-to-event data into meta-analysis

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.

Programmed cell death ligand 1 expression in osteosarcoma.

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

Prognostic significance of histological invasion in high grade soft tissue sarcomas.

P304

e11004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1097/MD.0000000000011004

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29923984

http://www.w3.org/2001/XMLSchema#string

P932

6024480

http://www.w3.org/2001/XMLSchema#string